It's important, now more than ever, for Blacks to talk to their doctors about the possibility of participating in clinical ...
A study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of the University of Pennsylvania ...
Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...
Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...
Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...
Trial underscores IROS's commitment to developing innovative therapies for unmet medical needs <li /> The study's success ...
An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...
Imagine having a digital carbon copy of yourself that physicians could use to predict long-term risks for disease, assess how your body may respond to treatment, and simulate surgeries in advance. A ...
A multidisciplinary team of University of Miami researchers studying factors associated with health outcomes and disease risk in the Hispanic community has received a $21 million grant from the ...
Because of the risks biopsies can pose to patients, the FDA recommends only requiring them as part of trial participation if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback